Record-breaking AI technology delivering rapid intelligence from unstructured healthcare data
Focus time, money, and resources more effectively to deliver better, more affordable healthcare
Helping address complex challenges in healthcare and life sciences, such as population health and identifying patients for clinical trials
Developed over ten years of R&D and trusted by leading pharmaceutical and healthcare organisations, Clinithink's CLiX® intelligence platform uses Artificial Intelligence to create rich and structured meaning from the unstructured narrative within a patient’s electronic medical record (EMR).
Designed by clinicians, Clinithink's patented CLiX technology has been developed to offer the most advanced query capabilities - capabilities that can turn unstructured narrative data into valuable, focused insights.
The CLiX intelligence platform provides the foundation for a suite of AI based targeted solutions, covering the unique demands of Real-World Evidence, Revenue Cycle Management, Population Health and Rare Disease. In doing so, Clinithink is helping solve some of the most complex challenges in healthcare today.
Clinithink’s patented technology underpins the CLiX® intelligence platform, which provides the foundation for our range of AI solutions.
By rapidly surfacing vital insights from vast untapped sources of data, Clinithink's CLiX® technology, enables our customers and partners to focus their time, money and resources more effectively.
The CLiX intelligence platform utilises state-of-the-art enterprise class technologies ensuring not just superior levels of performance, reliability and scalability, but robust security features as well as seamless integration with the healthcare data ecosystem.
CLiX intelligence is capable of processing large quantities of unstructured data (contained within electronic medical documents) in only a matter of milliseconds.
CLiX intelligence is also able to understand a vast number of unique and detailed clinical concepts, including variations that relate to; negation, certainty, severity, laterality and temporality. It can decipher a large range of misspellings and acronyms, based on its exposure to more than 4 billion words of English medical text. Plus, it can derive computable structured data from free-text by using a patented technique that maps the input data it ‘reads’, and comparing it to the structured clinical vocabulary of SNOMED clinical terms, using a comprehensive language model, developed over more than a decade.
CLiX® technology can process and analyse millions of clinical documents in just a matter of hours - instead of the months or years it would otherwise take clinicians to review manually.
CLiX intelligence provides a performant, secure and robust enterprise class architecture that scales effortlessly to support high levels of concurrent users working with very large datasets.
Onsite application within your existing security infrastructure gives you the power to maintain control over data and security, ensuring the highest level of protection for patient information.
Application and database server configuration provided saving time and effort for hard-pressed IT teams.
"Having carefully evaluated Clinithink, we have partnered with them to bring this automation process to our system in a strategic ten-year deal. With Clinithink, we can now extend our revenue cycle review without increasing staff costs. This, along with support for denials management will enable us to use Clinithink’s cutting-edge technology in critical revenue cycle activities which in turn ensure that we can continue to meet the needs of our patients."
"We are pleased to have worked with Clinithink and The Access Group within the pilot phase of this exciting new technology addressing patient data analysis.
In the limited time a clinician has to prepare for an appointment, the in-depth analysis of the unstructured notes that this system can achieve simply wouldn’t be possible manually."
"Some people call this artificial intelligence, we call it augmented intelligence.
Patient care will always begin and end with the doctor and by harnessing the power of technology we can quickly and accurately determine the root cause of genetic diseases."